<VariationArchive VariationID="2585639" VariationName="NM_058172.6(ANTXR2):c.1139del (p.Tyr380fs)" VariationType="Deletion" Accession="VCV002585639" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-06" DateCreated="2023-10-28" MostRecentSubmission="2023-10-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2753199" VariationID="2585639">
      <GeneList>
        <Gene Symbol="ANTXR2" FullName="ANTXR cell adhesion molecule 2" GeneID="118429" HGNC_ID="HGNC:21732" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q21.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="79901146" stop="80073472" display_start="79901146" display_stop="80073472" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="80822770" stop="80994476" display_start="80822770" display_stop="80994476" Strand="-" />
          </Location>
          <OMIM>608041</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_058172.6(ANTXR2):c.1139del (p.Tyr380fs)</Name>
      <CanonicalSPDI>NC_000004.12:79983917:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q21.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="79983918" stop="79983918" display_start="79983918" display_stop="79983918" variantLength="1" positionVCF="79983917" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="80905072" stop="80905072" display_start="80905072" display_stop="80905072" variantLength="1" positionVCF="80905071" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>Y380fs</ProteinChange>
      <ProteinChange>Y303fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.80905072del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.80905072del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.79983918del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.79983918del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015987.1" sequenceAccession="NG_015987" sequenceVersion="1" change="g.94406del">
            <Expression>NG_015987.1:g.94406del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145794.2" sequenceAccession="NM_001145794" sequenceVersion="2" change="c.1139del">
            <Expression>NM_001145794.2:c.1139del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001139266.1" sequenceAccession="NP_001139266" sequenceVersion="1" change="p.Tyr380fs">
            <Expression>NP_001139266.1:p.Tyr380fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286780.2" sequenceAccession="NM_001286780" sequenceVersion="2" change="c.908del">
            <Expression>NM_001286780.2:c.908del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001273709.1" sequenceAccession="NP_001273709" sequenceVersion="1" change="p.Tyr303fs">
            <Expression>NP_001273709.1:p.Tyr303fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286781.2" sequenceAccession="NM_001286781" sequenceVersion="2" change="c.908del">
            <Expression>NM_001286781.2:c.908del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001273710.1" sequenceAccession="NP_001273710" sequenceVersion="1" change="p.Tyr303fs">
            <Expression>NP_001273710.1:p.Tyr303fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058172.6" sequenceAccession="NM_058172" sequenceVersion="6" change="c.1139del" MANESelect="true">
            <Expression>NM_058172.6:c.1139del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_477520.2" sequenceAccession="NP_477520" sequenceVersion="2" change="p.Tyr380fs">
            <Expression>NP_477520.2:p.Tyr380fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_058172.6(ANTXR2):c.1139del (p.Tyr380fs) AND Hyaline fibromatosis syndrome" Accession="RCV003338921" Version="2">
        <ClassifiedConditionList TraitSetID="8864">
          <ClassifiedCondition DB="MedGen" ID="C5574677">Hyaline fibromatosis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-10-28" MostRecentSubmission="2023-10-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8864" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9509" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hyaline fibromatosis syndrome</ElementValue>
                <XRef ID="Fibromatosis+Juvenile+Hyaline/2851" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009229" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyalinosis, Inherited Systemic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYALINOSIS, SYSTEMIC</ElementValue>
                <XRef Type="MIM" ID="228600" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HFS</ElementValue>
                <XRef Type="MIM" ID="228600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22029" />
                <XRef ID="22029" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hyaline fibromatosis syndrome (HFS) is characterized by hyaline deposits in the papillary dermis and other tissues. It can present at birth or in infancy with severe pain with movement, progressive joint contractures, and often with severe motor disability, thickened skin, and hyperpigmented macules/patches over bony prominences of the joints. Gingival hypertrophy, skin nodules, pearly papules of the face and neck, and perianal masses are common. Complications of protein-losing enteropathy and failure to thrive can be life threatening. Cognitive development is normal. Many children with the severe form (previously called infantile systemic hyalinosis) have a significant risk of morbidity or mortality in early childhood; some with a milder phenotype (previously called juvenile hyaline fibromatosis) survive into adulthood.</Attribute>
                <XRef ID="NBK1525" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301698</ID>
                <ID Source="BookShelf">NBK1525</ID>
              </Citation>
              <XRef ID="2028" DB="Orphanet" />
              <XRef ID="498474" DB="Orphanet" />
              <XRef ID="C5574677" DB="MedGen" />
              <XRef ID="MONDO:0009229" DB="MONDO" />
              <XRef Type="MIM" ID="228600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7575729" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="20300109824" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004047310" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift variant c.1139del (p.Tyr380PhefsTer29) in ANTXR2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Tyr380PhefsTer29 variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. This variant causes a frameshift starting with codon Tyrosine 380, changes this amino acid to Phenylalanine residue, and creates a premature Stop codon at position 29 of the new reading frame, denoted p.Tyr380PhefsTer29. This variant is predicted to cause loss of normal protein function. Loss of function variants have been previously reported to be disease causing. This is a frameshift termination variant in Exon14 and a pathogenic missense variant at 381 position has been reported in clinvar ANTXR2;Tyr381Cys . For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002829" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0009473" />
              </Trait>
              <Comment>Consanguinity: Absent Clinical symptoms: Pain in joint movements, excessive/persistent cry but developmentally normal. On Examination: tightness of all joints (ankle/ wrist) and discoloration of skin at knuckles. Family history: Elder sister succumbed at 6, months of age with similar issues and suspicion of heart defect and failure to thrive. Clinical suspicion: Infantile Systemic Hyalinosis</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANTXR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_058172.6:c.1139del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="228600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13901154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7575729" TraitType="Finding" MappingType="XRef" MappingValue="HP:0009473" MappingRef="HP">
        <MedGen CUI="C0158113" Name="Joint contracture of the hand" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575729" TraitType="Disease" MappingType="XRef" MappingValue="228600" MappingRef="OMIM">
        <MedGen CUI="C5574677" Name="Hyaline fibromatosis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575729" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002829" MappingRef="HP">
        <MedGen CUI="C0003862" Name="Arthralgia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

